AZN vs RMNI · P/E 28, $288.38B cap vs P/E 12, rev $216.5M
AstraZeneca PLC (AZN) versus Rimini Street Inc (RMNI) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Rimini Street Inc (RMNI) is a software - application company listed on NASDAQ.
AZN does not have a complete income-statement cache yet.
Latest reported RMNI revenue for 2026-06-30 was $216.5M. Net income was $3.8M. RMNI currently screens at market cap $385.5M and trailing P/E 11.6.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. RMNI currently screens at market cap $385.5M and trailing P/E 11.6.
Not investment advice. Open the AZN and RMNI stock pages for the full models.
Not investment advice.